216 related articles for article (PubMed ID: 34136107)
1. Oncogenic RAS drives the CRAF-dependent extracellular vesicle uptake mechanism coupled with metastasis.
Choi D; Montermini L; Meehan B; Lazaris A; Metrakos P; Rak J
J Extracell Vesicles; 2021 Jun; 10(8):e12091. PubMed ID: 34136107
[TBL] [Abstract][Full Text] [Related]
2. Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras.
Lee TH; Chennakrishnaiah S; Meehan B; Montermini L; Garnier D; D'Asti E; Hou W; Magnus N; Gayden T; Jabado N; Eppert K; Majewska L; Rak J
Oncotarget; 2016 Aug; 7(32):51991-52002. PubMed ID: 27437771
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation.
Choi D; Lee TH; Spinelli C; Chennakrishnaiah S; D'Asti E; Rak J
Semin Cell Dev Biol; 2017 Jul; 67():11-22. PubMed ID: 28077296
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis.
Costa Verdera H; Gitz-Francois JJ; Schiffelers RM; Vader P
J Control Release; 2017 Nov; 266():100-108. PubMed ID: 28919558
[TBL] [Abstract][Full Text] [Related]
6. FAM83B mediates EGFR- and RAS-driven oncogenic transformation.
Cipriano R; Graham J; Miskimen KL; Bryson BL; Bruntz RC; Scott SA; Brown HA; Stark GR; Jackson MW
J Clin Invest; 2012 Sep; 122(9):3197-210. PubMed ID: 22886302
[TBL] [Abstract][Full Text] [Related]
7. Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma.
Luan Z; He Y; Alattar M; Chen Z; He F
Mol Cancer; 2014 Feb; 13():38. PubMed ID: 24568222
[TBL] [Abstract][Full Text] [Related]
8. Oncogene-dependent survival of highly transformed cancer cells under conditions of extreme centrifugal force - implications for studies on extracellular vesicles.
Lee TH; Chennakrishnaiah S; Rak J
Cell Mol Biol Lett; 2015 Mar; 20(1):117-29. PubMed ID: 26204397
[TBL] [Abstract][Full Text] [Related]
9. Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells.
Tu C; Du Z; Zhang H; Feng Y; Qi Y; Zheng Y; Liu J; Wang J
Theranostics; 2021; 11(5):2364-2380. PubMed ID: 33500730
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts.
Kong J; Tian H; Zhang F; Zhang Z; Li J; Liu X; Li X; Liu J; Li X; Jin D; Yang X; Sun B; Guo T; Luo Y; Lu Y; Lin B; Liu T
Mol Cancer; 2019 Dec; 18(1):175. PubMed ID: 31796058
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells.
Hoogwater FJ; Nijkamp MW; Smakman N; Steller EJ; Emmink BL; Westendorp BF; Raats DA; Sprick MR; Schaefer U; Van Houdt WJ; De Bruijn MT; Schackmann RC; Derksen PW; Medema JP; Walczak H; Borel Rinkes IH; Kranenburg O
Gastroenterology; 2010 Jun; 138(7):2357-67. PubMed ID: 20188103
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of extracellular vesicle uptake in stressed retinal pigment epithelial cell monolayers.
Nicholson C; Shah N; Ishii M; Annamalai B; Brandon C; Rodgers J; Nowling T; Rohrer B
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165608. PubMed ID: 31740401
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells.
Lee TH; Chennakrishnaiah S; Audemard E; Montermini L; Meehan B; Rak J
Biochem Biophys Res Commun; 2014 Aug; 451(2):295-301. PubMed ID: 25086355
[TBL] [Abstract][Full Text] [Related]
14. Role for extracellular vesicles in the tumour microenvironment.
O'Loghlen A
Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158316
[TBL] [Abstract][Full Text] [Related]
15. The key role of extracellular vesicles in the metastatic process.
Zhao H; Achreja A; Iessi E; Logozzi M; Mizzoni D; Di Raimo R; Nagrath D; Fais S
Biochim Biophys Acta Rev Cancer; 2018 Jan; 1869(1):64-77. PubMed ID: 29175553
[TBL] [Abstract][Full Text] [Related]
16. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.
Commisso C; Davidson SM; Soydaner-Azeloglu RG; Parker SJ; Kamphorst JJ; Hackett S; Grabocka E; Nofal M; Drebin JA; Thompson CB; Rabinowitz JD; Metallo CM; Vander Heiden MG; Bar-Sagi D
Nature; 2013 May; 497(7451):633-7. PubMed ID: 23665962
[TBL] [Abstract][Full Text] [Related]
17. Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesicles.
Chennakrishnaiah S; Meehan B; D'Asti E; Montermini L; Lee TH; Karatzas N; Buchanan M; Tawil N; Choi D; Divangahi M; Basik M; Rak J
J Thromb Haemost; 2018 Sep; 16(9):1800-1813. PubMed ID: 29971917
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicle docking at the cellular port: Extracellular vesicle binding and uptake.
French KC; Antonyak MA; Cerione RA
Semin Cell Dev Biol; 2017 Jul; 67():48-55. PubMed ID: 28104520
[TBL] [Abstract][Full Text] [Related]
19. Active Ras induces heterodimerization of cRaf and BRaf.
Weber CK; Slupsky JR; Kalmes HA; Rapp UR
Cancer Res; 2001 May; 61(9):3595-8. PubMed ID: 11325826
[TBL] [Abstract][Full Text] [Related]
20. Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors.
Jaiswal BS; Janakiraman V; Kljavin NM; Eastham-Anderson J; Cupp JE; Liang Y; Davis DP; Hoeflich KP; Seshagiri S
PLoS One; 2009 May; 4(5):e5717. PubMed ID: 19492075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
